Mckesson Corp
MCKToday
-1.45%
5 Days
+1.74%
1 Month
+4.31%
6 Months
-1.01%
Year to Date
+11.02%
1 Year
+32.61%
Mckesson Corp Stock (MCK) Moved Up by 3.13% on Sep 1: Key Drivers Unveiled
• McKesson agreed to acquire Precision Medicine Group to expand its oncology portfolio. • The company raised its quarterly dividend payout by fifteen percent. • Annual revenue reached $403.43 billion, ranking first in the industry.
Mckesson Corp Stock (MCK) Moved Up by 3.25% on Aug 25: What Signal Does It Send?
• McKesson agreed to acquire Precision Medicine Group for $2.25 billion. • Q1 revenue and earnings exceeded estimates, prompting higher full-year guidance. • Annual revenue reached $403.43B, ranking first in the pharmaceutical industry.
Mckesson Corp Stock (MCK) Moved Up by 3.13% on Aug 21: A Full Analysis
• McKesson exceeded Wall Street estimates and raised full-year earnings guidance. • Strong cash flow drove share repurchases and a dividend increase. • Analysts issued Buy ratings with an average price target of $979.83.
Mckesson Corp Stock (MCK) Moved Down by 3.44% on Aug 6: What Signal Does It Send?
• McKesson shares declined following margin contraction in the U.S. Pharmaceutical segment. • Management maintained full-year earnings guidance, disappointing investors seeking an upward revision. • Regulatory scrutiny regarding drug pricing and reimbursement creates significant uncertainty for the firm.
Mckesson Corp Stock (MCK) Closed Up by 5.08% on Aug 5: What Investors Need To Know
• McKesson reported fiscal first-quarter earnings exceeding consensus expectations across core metrics. • Management raised full-year earnings guidance, citing strength in oncology and biopharma services. • The company leads its industry with $403.43 billion in latest annual revenue.
Novo Nordisk A/S Stock (NVO) Moved Down by 3.09% on May 15: Drivers Behind the Movement
• Novo Nordisk's share price fell due to competition and sales outlook concerns. • Eli Lilly's GLP-1 products intensify competition for Novo Nordisk. • U.S. pricing pressures and sales contraction outlook weigh on the stock.
Mckesson Corp's Score
Media Coverage
Analyst Rating
Mckesson Corp Technical Analysis
Technical Indicators
Summary
Moving Average
Financial Indicators
Earnings
Mckesson Corp Profile
Ownership
| Shareholders | Proportion |
|---|---|
| Vanguard Capital Management, LLC | 6.62% |
| BlackRock Institutional Trust Company, N.A. | 5.74% |
| State Street Investment Management (US) | 4.81% |
| MFS Investment Management | 2.81% |
| Shareholder Types | Proportion |
|---|---|
| Investment Advisor | 48.66% |
| Investment Advisor/Hedge Fund | 32.95% |
| Pension Fund | 3.22% |
| Research Firm | 2.88% |
Related Instruments
Popular Instruments
